Skip to main content
. 2019 Sep 26;40(9):1869–1878. doi: 10.1177/0271678X19877403

Table 2.

Association between CMI presence and cerebral perfusion adjusted for covariates.

CBF (N = 148) B (95% CI) p CBFpvc (N = 148) B (95% CI) p Spatial CoV (N = 181) B (95% CI) p
Model 1: CMI presence −6.1 (−11.1; −1.2) .016 −6.5 (−12.9; −.2) .044 .08 (.02; .14) .006
Model 2: CMI + age, sex −5.0 (−9.7; −.2) .038 −5.6 (−11.9; .6) .078 .06 (.003; .11) .039
Model 3: CMI + age, sex + 
 Hypertension −4.6 (−9.3; .1) .054 −5.1 (−11.4; 1.1) .106 .05 (−.005; .10) .079
 Hypercholesterolemia −4.4 (−9.3; .4) .073 −4.8 (11.2; 1.6) .143 .05 (−.006; .10) .082
 Diabetes −4.5 (−9.3; .2) .061 −5.3 (−11.7; 1.0) .098 .06 (.003; .11) .040
 Current smoking −5.2 (−9.9; −.4)) .033 5.8 (−12.1; .5) .072 .05 (.001; .11) .045
 Obesity −5.0 (−9.9; −.1) .044 −6.2 (−12.7; .4) .064 .06 (.004; .11) .034
 History of stroke −5.7 (−10.5; −1.0) .018 −4.9 (−11.2; 1.4) .126 .05 (.001; .11) .047
 Cardiac disease −4.5 (−9.2; .3) .065 −6.4 (−12.7; −.1) .048 .05 (−.01; .10) .122
 All vascular risk factors −4.8 (−9.8; .3) .066 −5.7 (−12.5; 1.0) .096 .05 (−.005; .11) .075
Model 4: CMI + age, sex + 
 Total brain volume −3.7 (−8.2; .8) .110 −4.5 (−10.7; 1.7) .154 .04 (−.01; .10) .104
 WMH volumea −3.1 (−7.8; 1.7) .200 −3.6 (−10.0; 2.8) .265 .03 (−.02; .09) .210
 Presence of cortical infarcts −5.0 (−10.0; −.1) .045 −5.6 (−12.2; .9) .090 .05 (−.003; .11) .064
 Presence of subcortical infarcts −4.6 (−9.5; .2) .059 −5.0 (−11.4; 1.4) .122 .05 (−.001; .11) .048
 Presence of microbleeds −4.2 (−8.9; .6) .086 −4.4 (−10.7; 1.9) .171 .05 (−.004; .10) .069
 Presence intracranial stenosis −4.4 (−9.2; .4) .073 −5.0 (−11.4; 1.5) .128 .05 (−.003; .10) .064
 All imaging markers −1.1 (−6.0; 3.9) .670 −1.2 (−8.1; 5.6) .727 .02 (−.04; .07) .581

CBF: cerebral blood flow; CBFpvc: partial volume corrected cerebral blood flow; spatial CoV: spatial coefficient of variation of the cerebral blood flow; CMI: cerebral cortical microinfarct; WMH: white matter hyperintensity.

Data presented as B: mean difference between patients with and without CMIs and the 95% confidence interval. Model 1: unadjusted; model 2: adjusted for age and sex; model 3: adjusted for age, sex and each individual vascular risk factor added separately; model 4: adjusted for age, sex and each individual neuro-imaging marker added separately.

a

WMH volume was entered into the analysis after a logarithmic transformation of the data.